Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease

NCT03422627 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

32

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Chronic Graft Versus Host Disease cGVHD

Interventions

DRUG: Efavaleukin Alfa

Sponsor

Amgen